Glutamate-type hypothalamic-pituitary syndrome in mice treated with aspartate or cysteate in infancy.
D000272:Adipates / Q000494:pharmacology / Q000633:toxicity; D000409:Alanine / Q000494:pharmacology*; D000600:Amino Acids, Dicarboxylic / Q000494:pharmacology*; D000603:Amino Acids, Sulfur / Q000494:pharmacology*; D000818:Animals; D000831:Animals, Newborn; D001224:Aspartic Acid / Q000494:pharmacology*; D001835:Body Weight; D001927:Brain Diseases / Q000139:chemically induced / Q000150:complications / Q000473:pathology; D005260:Female; D007018:Hypopituitarism / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects*; D007031:Hypothalamus / Q000473:pathology; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009474:Neurons / Q000187:drug effects*; D009765:Obesity / Q000209:etiology*; D009929:Organ Size; D010053:Ovary / Q000473:pathology; D010903:Pituitary Gland, Anterior / Q000473:pathology; D012737:Sex Factors; D013737:Testis / Q000473:pathology
D000272:Adipates; D000600:Amino Acids, Dicarboxylic; D000603:Amino Acids, Sulfur; D001224:Aspartic Acid; D000409:Alanine